Journals / Nöropsikiyatri Arşivi / 2022 / Cilt: 59 - Sayı: 2

Association of BDNF Gene Val66Met Polymorphism with Suicide Attempts, Focused Attention and Response Inhibition in Patients with Schizophrenia

Şizofreni Hastalarında BDNF Geni Val66Met Polimorfizminin İntihar Girişimi, Odaklanmış Dikkat ve Yanıt İnhibisyonu ile İlişkisi

Pages
91–97
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Impairment in executive function areas, such as focused attention and response inhibition appears to be related to the Met allele.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The relationship between BDNF gene Val/Met polymorphism and clinical symptoms, attention and executive functions in patients with schizophrenia was investigated in this study.
📊
Key Findings & Data:Also, BDNF Val66Met gene polymorphism was compared between patients and healthy controls.
💡
Conclusion & Impact:Impairment in executive function areas, such as focused attention and response inhibition appears to be related to the Met allele.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The relationship between BDNF gene Val/Met polymorphism and clinical symptoms, attention and executive functions in patients with schizophrenia was investigated in this study. Also, BDNF Val66Met gene polymorphism was compared between patients and healthy controls. Thus, genetic factors that may affect both the etiology and cognitive function of schizophrenia were evaluated. Methods: BDNF Val66Met gene polymorphism was investigated in 102 patients with schizophrenia and 98 healthy controls. Cognitive functions were evaluated by the Wisconsin Card Sorting Test (WCST) and Stroop Test. Results: There was no difference in terms of the genotypic or allelic distribution of BDNF Val66Met polymorphism between patients and healthy controls. A significantly higher percentage of suicide attempts were found in the patients having Met allele (Val/Met and Met/Met). Met allele was associated with failure in focused attention and response inhibition in patients with schizophrenia. Conclusion: The presence of the Met allele could be associated with the risk of suicide attempts in patients with schizophrenia. Impairment in executive function areas, such as focused attention and response inhibition appears to be related to the Met allele.

Özet

Amaç: Bu çalışmada remisyondaki şizofreni hastalarında BDNF geni Val66Met polimorfizmi ile klinik belirtiler, dikkat ve yürütücü işlevler arasındaki ilişki araştırıldı. Ayrıca BDNF geni Val66Met polimorfizmi, dikkat ve yürütücü işlevler sağlıklı kontroller ile şizofreni hastaları arasında karşılaştırıldı. Böylece hem şizofreni etiyolojisini hem de bilişsel işlevleri etkileyebilecek genetik faktörler değerlendirildi. Yöntem: BDNF Val66Met gen polimorfizmi 102 şizofreni hastasında ve 98 sağlıklı kontrolde araştırıldı. Bilişsel işlevler Wisconsin Kart Eşleme Testi (WKET) ve Stroop Testi ile değerlendirildi. Bulgular: Hastalar ve sağlıklı kontroller arasında BDNF Val66Met polimorfizminin genotipik veya allel dağılımı açısından fark yoktu. Met aleli olan hastalarda (Val/Met ve Met/Met) anlamlı olarak daha yüksek intihar girişimi yüzdesi bulundu. Met aleli, şizofreni hastalarında odaklanmış dikkat ve yanıt inhibisyonundaki başarısızlıkla ilişkiliydi. Sonuç: Met allelinin varlığı, şizofreni hastalarında intihar girişimi riski ile ilişkili olabilir. Odaklanmış dikkat ve yanıt inhibisyonu gibi yürütücü işlev alanlarındaki bozulma, Met alleli ile ilişkili görünmektedir.

🔖

Cite This Article

DİLBAZ, N., KAYA, H., KAHVE, A. C., KAYA, Ö. B., DARÇIN, A. E., ÇAVUŞ, R. S. Y. (2022). Association of BDNF Gene Val66Met Polymorphism with Suicide Attempts, Focused Attention and Response Inhibition in Patients with Schizophrenia. Nöropsikiyatri Arşivi, Cilt: 59 - Sayı: 2, 91–97. https://ajindex.com/articles/584576

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Dieci M, Vita A, Silenzi C, Caputo A, Comazzi M, Ferrari L ve ark. Nonselective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia. Schizophr Res 1997
  2. 33–42. [Crossref] 2. Tost H, Alam T, Meyer-Lindenberg A. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 2010
  3. 689–700. [Crossref] 3. Waterhouse EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 2009
  4. 81–89. [Crossref] 4. Hanson IM, Seawright A, van Heyningen V. The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13-p14. Genomics 1992
  5. 1331–1333. [Crossref] 5. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A ve ark. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003
  6. 257–269. [Crossref] 6. Notaras M, Hill R, van den Buuse M. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. Neurosci Biobehav Rev 2015
  7. 15–30. [Crossref] 7. Utami N, Effendy E, Amin M. The Relation of Brain-Derived Neurotropic Factor (BDNF) Serum Level to Sub-Domain Cognitive Functions of Indonesian Schizophrenia Patients Measured by MoCA-Ina. Open Access Maced J Med Sci 2019
  8. 4053–4058. [Crossref] 8. Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A ve ark. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci 2006
  9. 70–76. [Crossref] 9. Andreasen NC, Carpenter Jr WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005
  10. 441–449. [Crossref] 10. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders (SCID-I). Clinician version. USA: American Psychiatric Press
  11. https://www.amazon.com/Structured-Interview- Disorders-Clinician-Administration/dp/0880489324 11. Ozkurkcugil A, Aydemir O, Yildiz M, Esen Danaci A, Koroglu E. Structured clinical interview for DSM-IV axis I disorders-clinical version (SCID-CV) in Turkish: study of reliability. ScienceOpen 1999. https://www.scienceopen. com/document?vid=4d72484d-721f-4937-ac46-4f53d4f4b7d3 12. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtis G, Curtiss G ve ark. Wisconsin Card Sorti